GGrantIndex
Sort

53,477 grants matching addiction

Patient Feedback Effectiveness Study

$511,346
Paul F Crits-Christoph · University Of Pennsylvania · R01 · FY2006 · DA

Investigating the role of metabolic rewiring in breast tumor innervation

$511,284
Younghye Song · University Of Arkansas At Fayetteville · R37 · FY2024 · CA

A dose ranging study of modafinil for methamphetamine dependence

$511,263
Gantt P Galloway · California Pacific Med Ctr Res Institute · R01 · FY2012 · DA

SUMO modification and cancer therapy

$511,259
Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2015 · GM

Integrative Genetics and Genomics

$511,249
Vivek Philip · Jackson Laboratory · P50 · FY2018 · DA

A dose ranging study of modafinil for methamphetamine dependence

$511,223
Gantt P Galloway · California Pacific Med Ctr Res Institute · R01 · FY2010 · DA

Influence of Orexin Antagonism on Motivation for Alcohol

$511,216
William Walton Stoops · University Of Kentucky · R01 · FY2025 · AA

High throughput in vivo screening: translational generation of novel analgesics

$511,211
Richard A Houghten · Torrey Pines Inst For Molecular Studies · R01 · FY2013 · DA

Postdoctoral training in tobacco control

$511,207
Stanton Arnold Glantz · University Of California, San Francisco · R25 · FY2007 · CA

RADX BLUEPRINT MEDTECH TRANSLATOR COHORT 2 - COMMERCIALIZATION CENTER - HEAL

$511,206
Venturewell · N02 · FY2025 · HL

Data Structures, Algorithms and Tools for Ontological Discovery

$511,090
Elissa J Chesler · Jackson Laboratory · R01 · FY2011 · AA

Examining the role of novel proenkephalin peptides in influencing alcohol-induced cognitive dysfunction

$511,059
Luis Alberto Natividad · University Of Texas At Austin · R01 · FY2024 · AA

Psychotherapy Development Research Center

$511,033
Kathleen M Carroll · Yale University · P50 · FY2013 · DA

Neurocognitive Change Associated w/ Behavioral Treatment

$510,925
Hartford Hospital · R01 · FY2005 · DA

Mechanisms of Synaptic Dopamine Signaling in the Control of Behavior

$510,867
Niels Ringstad · New York University School Of Medicine · R01 · FY2024 · NS

TEEN SMOKING PREVENTION AND CESSATION VIA CD ROM PROGRAM

$510,807
University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA

Studies with Nicotinic Null Mutant Mice

$510,678
Allan C Collins · University Of Colorado · P30 · FY2009 · DA

5‐HT2CR ALLOSTERIC MODULATORS AS NOVEL PHARMACOTHERAPY IN COCAINE USE DISORDER

$510,641
Jia Zhou · University Of Texas Med Br Galveston · R01 · FY2016 · DA

Nicotinic Receptor Template-guided Drug Design

$510,601
University Of California San Diego · U01 · FY2004 · DA

Test of a Workforce Development Intervention to Expand Buprenorphine Prescribers

$510,550
Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2019 · DA

The effect of menthol on ENDS users' dependence, respiratory, and toxicants emission outcomes

$510,525
Wasim Maziak · Florida International University · R01 · FY2022 · DA

Molecular Pathogenesis of Multiple Myeloma

$510,465
Walter Kuehl · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Neural Mechanisms of Habit Formation and Maintenance

$510,454
Henry Yin · Duke University · R01 · FY2012 · AA

Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy

$510,416
Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA

Do Practice Guidelines Reduce Smoking in Schizophrenia

$510,405
University Of Maryland Baltimore · R01 · FY2002 · DA